Skip to main content
Nanobiotix S.A. (EPA:NANO)
France flag France · Delayed Price · Currency is EUR
33.50
+4.85 (16.93%)
At close: Mar 9, 2026

Nanobiotix Revenue

Nanobiotix had revenue of 26.64M EUR in the half year ending June 30, 2025, with 708.93% growth. This brings the company's revenue in the last twelve months to 10.16M, down -75.93% year-over-year. In the year 2024, Nanobiotix had annual revenue of -7.19M, down -119.86%.

Revenue (ttm)
10.16M
Revenue Growth
-75.93%
P/S Ratio
159.70
Revenue / Employee
98.63K
Employees
103
Market Cap
1.62B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024-7.19M-43.40M-119.86%
Dec 31, 202336.21M31.43M658.12%
Dec 31, 20224.78M2.13M80.43%
Dec 31, 20212.65M322.00K13.85%
Dec 31, 20202.33M-216.00K-8.50%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
DBV Technologies 4.69M
Inventiva 16.97M
Valneva SE 179.91M
MedinCell 32.44M
Genfit 45.13M
ABIVAX Société Anonyme 5.31M
Cellectis 70.36M
Transgene 7.58M
Revenue Rankings

Nanobiotix News

More News